MEDEZE Receives Frost & Sullivan's 2025 Southeast Asia Company of the Year Recognition for Leadership in Stem Cell Banking and Regenerative Medicine
The company is revolutionizing regenerative healthcare through innovation, clinical alignment, and GMP-grade excellence across Southeast Asia SAN ANTONIO, Dec. 15, 2025 /PRNewswire/ -- Frost & Sullivan is pleased to announce that MEDEZE Group...
Singtel Receives Frost & Sullivan's 2025 Singapore Company of the Year Recognition in Cybersecurity Services Leadership
Singapore's national leader in integrated cyber resilience is acknowledged for driving measurable market impact, innovation, and customer-first security transformation. SAN ANTONIO, Dec. 12, 2025 /PRNewswire/ -- Frost & Sullivan is pleased to...
Mazdutide Demonstrates Significant Weight Loss and Metabolic Benefits in Phase 1b Clinical Trial in Chinese Adolescents with Obesity
After 12 weeks of treatment, the 4 mg and 6 mg mazdutide groups achieved reductions in BMI from baseline of 8.78% and 10.99%, respectively, with corresponding body weight reductions of 7.72 kg and 8.65 kg. These results were significantly superior...
HanchorBio Announces Oral Presentation of HCB101 at the ESMO Immuno-Oncology Congress 2025
International debut underscores emerging role for macrophage checkpoint therapy in gastric cancer, triple-negative breast cancer, and other hard-to-treat solid tumors TAIPEI, SHANGHAI, AND SAN FRANCISCO, Dec. 11, 2025 /PRNewswire/ -- HanchorBio Inc....
Smart Energy in Action: JA Solar's first BESS for C&I in Sicily, Italy
PALERMO, Italy, Dec. 11, 2025 /PRNewswire/ -- JA Solar, a global leader in photovoltaic products and integrated energy solutions, announced the successful commissioning of a solar-plus-storage microgrid at a modern C&I facility in Sicily. This...
Imec demonstrates first wafer-scale fabrication of solid-state nanopores using EUV lithography
Breakthrough enables scalable, high-precision biosensing applications in life sciences and healthcare LEUVEN, Belgium, Dec. 9, 2025 /PRNewswire/ -- Imec has achieved the first successful wafer-scale fabrication of solid-state nanopores using EUV...
Innovent Announces PECONDLE® (Picankibart Injection) Phase 3 Study (CLEAR-2) Meets Endpoints, Delivering Superior Long-Term Management Solution for Moderate-to-Severe Psoriasis
SAN FRANCISCO and SUZHOU, China, Dec. 9, 2025 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of...
Halia Therapeutics Announces Positive Phase 2a Data for Ofirnoflast in Lower-Risk MDS at ASH 2025
– New findings demonstrate a 72% HI-E response rate at Week 16 with meaningful hemoglobin improvement – – Strong activity observed across ESA-refractory and ESA-intolerant patients, and across mutation and morphology subtypes – – Favorable safety...
Hypershell Publishes First Consumer Exoskeleton Standards White Paper, Calling for Industry-Wide Transparency and Unified Testing Frameworks
SGS-verified performance results underscore the need for reproducible, third-party testing across the emerging wearable robotics sector SHENZHEN, China, Dec. 8, 2025 /PRNewswire/ -- Hypershell, the originator of the outdoor consumer exoskeleton...
WiMi Studies Hybrid Quantum-Classical Learning Architecture for Multi-Class Image Classification
BEIJING, Dec. 5, 2025 /PRNewswire/ -- WiMi Hologram Cloud Inc. (NASDAQ: WiMi) ("WiMi" or the "Company"), is a leading global Hologram Augmented Reality ("AR") Technology provider. On the basis of in-depth research on quantum convolutional neural...